Sellas Life Sciences: The Internal Inconsistency Of An Assumed Positive REGAL Readout
Sellas Life Sciences Group Inc SLS
$8.96
▼ -2.40%
($-0.22)
Open
$9.25
Prev Close
$9.18
Day Range
$8.60 – $9.27
52W Range
$1.39 – $9.24
Market Cap
$1.71B
Beta
2.52
EPS (TTM)
$-0.23
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2008-03-12 |
| Shares Out. | 186,030,000 |
| Website | sellaslifesciences.com/ ↗ |
| Phone | 16462005278 |
Sellas Life Sciences Group Inc is a publicly traded company under the ticker symbol SLS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-05-01)
📰 Latest News for SLS
10 Health Care Stocks With Whale Alerts In Today's Session
Sellas Life Sciences: REGAL Delay May Be A Warning Sign, Not A Bullish Signal
12 Health Care Stocks Moving In Thursday's Intraday Session
TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday
SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?